Concord Medical Services Holdings Limited (NYSE:CCM – Get Free Report) was the recipient of a significant drop in short interest in October. As of October 15th, there was short interest totaling 6,821 shares, a drop of 37.5% from the September 30th total of 10,916 shares. Approximately 0.3% of the shares of the company are short sold. Based on an average daily volume of 11,855 shares, the short-interest ratio is currently 0.6 days.
Analyst Upgrades and Downgrades
A number of brokerages have recently issued reports on CCM. Wall Street Zen raised shares of Concord Medical Services to a “hold” rating in a report on Saturday, August 15th. Weiss Ratings reissued a “sell (e+)” rating on shares of Concord Medical Services in a report on Friday, August 21st. One research analyst has rated the stock with a Sell rating. According to MarketBeat, the stock presently has a consensus rating of “Sell”.
View Our Latest Stock Analysis on Concord Medical Services
Concord Medical Services Trading Up 3.1%
Concord Medical Services stock traded up $0.11 during mid-day trading on Monday, hitting $3.68. 3,655 shares of the company traded hands, compared to its average volume of 35,036. The stock has a fifty day moving average price of $3.90 and a 200-day moving average price of $4.20. Concord Medical Services has a one year low of $2.79 and a one year high of $6.80.
Concord Medical Services Company Profile
Concord Medical Services Holdings Limited was a China-based healthcare services company focused primarily on cancer treatment and diagnostic imaging. The company operated and managed medical facilities that provided radiotherapy, diagnostic imaging, and related oncology services, often through partnerships with hospitals and other healthcare institutions.
Its business also included the provision of medical equipment, technology, and management services to healthcare providers. Concord Medical’s facilities and partnerships were concentrated in China, with a focus on expanding access to specialized cancer diagnosis and treatment in major cities and regional medical centers.
Founded in 2006 and headquartered in Beijing, Concord Medical was historically led by founder and chief executive officer Dr.
Recommended Stories
- Five stocks we like better than Concord Medical Services
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AI—These 5 Stocks Are Getting Paid
Receive News & Ratings for Concord Medical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concord Medical Services and related companies with MarketBeat.com's FREE daily email newsletter.
